201 related articles for article (PubMed ID: 35528524)
1. Identification of Bioactive Compounds and Potential Mechanisms of Kuntai Capsule in the Treatment of Polycystic Ovary Syndrome by Integrating Network Pharmacology and Bioinformatics.
Li X; Ma J; Guo L; Dong C; Zhu G; Hong W; Chen C; Wang H; Wu X
Oxid Med Cell Longev; 2022; 2022():3145938. PubMed ID: 35528524
[TBL] [Abstract][Full Text] [Related]
2. Integrated bioinformatics and network pharmacology to explore the therapeutic target and molecular mechanisms of Bailing capsule on polycystic ovary syndrome.
Guan HR; Li B; Zhang ZH; Wu HS; He XL; Dong YJ; Su J; Lv GY; Chen SH
BMC Complement Med Ther; 2023 Dec; 23(1):458. PubMed ID: 38102584
[TBL] [Abstract][Full Text] [Related]
3. [
Gao M; Hong Y; Cui M; Huang J; Tan Y; Nie X
Nan Fang Yi Ke Da Xue Xue Bao; 2022 Jan; 42(1):1-12. PubMed ID: 35249865
[TBL] [Abstract][Full Text] [Related]
4. [Study on mechanism of Bushen Culuan Formula in treatment of polycystic ovary syndrome based on network pharmacology and molecular docking].
Ma K; Gong LJ; Chen YX; Tian CD
Zhongguo Zhong Yao Za Zhi; 2021 Jun; 46(11):2650-2659. PubMed ID: 34296561
[TBL] [Abstract][Full Text] [Related]
5. The mechanism of
Wu M; Liu H; Zhang J; Dai F; Gong Y; Cheng Y
J Pharm Pharm Sci; 2023; 26():11234. PubMed ID: 36942296
[No Abstract] [Full Text] [Related]
6. Investigating the active components of Huatan Tongjing decoction for the treatment of polycystic ovary syndrome via network pharmacology.
Yu J; Fu Y; Zeng L; Zheng Y
Chem Biol Drug Des; 2022 Oct; 100(4):515-524. PubMed ID: 35822313
[TBL] [Abstract][Full Text] [Related]
7. Exploring the Mechanism of Yi-Jing Decoction in Treating Polycystic Ovary Syndrome by Using Network Pharmacology.
Lin Y; Xiang L; Li X; Tang Q; Meng F; Chen W
Curr Med Chem; 2023; 30(21):2463-2474. PubMed ID: 35532255
[TBL] [Abstract][Full Text] [Related]
8. The effective compounds and mechanisms of Cang-Fu-Dao-Tan Formula in treating polycystic ovary syndrome based on UPLC/Q-TOF-MS/MS, network pharmacology and molecular experiments.
Hu W; Xie N; Zhu H; Jiang Y; Ding S; Ye S; Zhang S; Wang F; Qu F; Zhou J
J Pharm Biomed Anal; 2024 Feb; 239():115867. PubMed ID: 38061171
[TBL] [Abstract][Full Text] [Related]
9. Network Pharmacology-Based Strategy for Predicting Active Ingredients and Potential Targets of
Ma JX; Ye M; Ma K; Zhou K; Zhang Y; Wang X; Tong H
Evid Based Complement Alternat Med; 2021; 2021():6651307. PubMed ID: 34457027
[TBL] [Abstract][Full Text] [Related]
10. Exploring the molecular targets and mechanism of
Yu H; Zhang L; Yin F; Zhan C; Chen J; Chu J
Ann Transl Med; 2023 Feb; 11(3):149. PubMed ID: 36846000
[TBL] [Abstract][Full Text] [Related]
11. Network pharmacology and molecular docking study on the treatment of polycystic ovary syndrome with angelica sinensis- radix rehmanniae drug pair.
Li X; Ullah I; Hou C; Liu Y; Xiao K
Medicine (Baltimore); 2023 Nov; 102(46):e36118. PubMed ID: 37986355
[TBL] [Abstract][Full Text] [Related]
12. [Identification of traditional Chinese drugs containing active ingredients for treating myocardial infarction and analysis of their therapeutic mechanisms by network pharmacology and molecular docking].
Zhao S; Liu K; Duan J; Tao X; Li W; Bai Y; Wei P; Xi M; Yang H
Nan Fang Yi Ke Da Xue Xue Bao; 2022 Jan; 42(1):13-25. PubMed ID: 35249866
[TBL] [Abstract][Full Text] [Related]
13. Network Pharmacology-Based and Molecular Docking-Based Analysis of Suanzaoren Decoction for the Treatment of Parkinson's Disease with Sleep Disorder.
Liu YY; Yu LH; Zhang J; Xie DJ; Zhang XX; Yu JM
Biomed Res Int; 2021; 2021():1752570. PubMed ID: 34660782
[TBL] [Abstract][Full Text] [Related]
14. Exploring the Molecular Mechanism of Action of Yinchen Wuling Powder for the Treatment of Hyperlipidemia, Using Network Pharmacology, Molecular Docking, and Molecular Dynamics Simulation.
Ye J; Li L; Hu Z
Biomed Res Int; 2021; 2021():9965906. PubMed ID: 34746316
[TBL] [Abstract][Full Text] [Related]
15. Network pharmacology and bioinformatics to identify molecular mechanisms and therapeutic targets of Ruyi Jinhuang Powder in the treatment of monkeypox.
Zhang X; Yu X; Yu Z; Fan C; Li Y; Li H; Shen Y; Sun Z; Zhang S
Medicine (Baltimore); 2023 Apr; 102(17):e33576. PubMed ID: 37115075
[TBL] [Abstract][Full Text] [Related]
16. Identification of potential bioactive compounds and mechanisms of GegenQinlian decoction on improving insulin resistance in adipose, liver, and muscle tissue by integrating system pharmacology and bioinformatics analysis.
Cao Z; Zeng Z; Wang B; Liu C; Liu C; Wang Z; Li S
J Ethnopharmacol; 2021 Jan; 264():113289. PubMed ID: 32846191
[TBL] [Abstract][Full Text] [Related]
17. Kuntai capsule attenuates premature ovarian insufficiency by activating the FOXO3/SIRT5 signaling pathway in mice: A comprehensive study using UHPLC-LTQ-Orbitrap and integrated pharmacology.
Gong L; Hou J; Yang H; Zhang X; Zhao J; Wang L; Yin X; Feng X; Yin C
J Ethnopharmacol; 2024 Mar; 322():117625. PubMed ID: 38145859
[TBL] [Abstract][Full Text] [Related]
18. Potential molecular mechanism of the Xiexin capsule in the intervention of dyslipidemia based on bioinformatics and molecular docking.
Yao K; Cai H; Wang Y; Cheng S; Liu Q; Zhang D; Chen Q; Chen X
Nutr Hosp; 2022 Jun; 39(3):569-579. PubMed ID: 35227068
[TBL] [Abstract][Full Text] [Related]
19. Study on the Mechanism of Liuwei Dihuang Pills in Treating Parkinson's Disease Based on Network Pharmacology.
Lin D; Zeng Y; Tang D; Cai Y
Biomed Res Int; 2021; 2021():4490081. PubMed ID: 34746302
[TBL] [Abstract][Full Text] [Related]
20. The bioinformatics analysis of quercetin in octagonal lotus for the screening of breast cancer MYC, CXCL10, CXCL11, and E2F1.
Ma Y; Peng Z; Pan R; Zhu Z; Meng X; Hu H; Qiao X; Huang X; Hou M
Int J Immunopathol Pharmacol; 2021; 35():20587384211040903. PubMed ID: 34693792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
